Petri M - Search Results

1

Myocardial T2 mapping by cardiovascular magnetic resonance reveals subclinical myocardial inflammation in patients with systemic lupus erythematosus.

Zhang Y, Corona-Villalobos CP, Kiani AN, Eng J, Kamel IR, Zimmerman SL, Petri M. Zhang Y, et al. Among authors: petri m. Int J Cardiovasc Imaging. 2015 Feb;31(2):389-97. doi: 10.1007/s10554-014-0560-3. Epub 2014 Oct 29. Int J Cardiovasc Imaging. 2015. PMID: 25352245

2

Soluble CD154 is not associated with atherosclerosis in systemic lupus erythematosus.

Kiani A, Mahoney JA, Petri M. Kiani A, et al. Among authors: petri m. J Rheumatol. 2007 May;34(5):969-72. Epub 2007 Apr 1. J Rheumatol. 2007. PMID: 17407217

3

Asymmetric dimethylarginine is a marker of poor prognosis and coronary calcium in systemic lupus erythematosus.

Kiani AN, Mahoney JA, Petri M. Kiani AN, et al. Among authors: petri m. J Rheumatol. 2007 Jul;34(7):1502-5. J Rheumatol. 2007. PMID: 17611963

4

Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity.

Kiani AN, Magder L, Petri M. Kiani AN, et al. Among authors: petri m. J Rheumatol. 2008 Jul;35(7):1300-6. Epub 2008 May 15. J Rheumatol. 2008. PMID: 18484694

5

Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis.

Kiani AN, Johnson K, Chen C, Diehl E, Hu H, Vasudevan G, Singh S, Magder LS, Knechtle SJ, Petri M. Kiani AN, et al. Among authors: petri m. J Rheumatol. 2009 Oct;36(10):2224-30. doi: 10.3899/jrheum.081112. Epub 2009 Jul 31. J Rheumatol. 2009. PMID: 19648301

6

Endogenous thrombin potential in the assessment of hypercoagulability in systemic lupus erythematosus.

Mehta BM, Kiani AN, Chen C, Jani J, Kickler TS, Petri M. Mehta BM, et al. Among authors: petri m. Am J Hematol. 2010 Jan;85(1):83-5. doi: 10.1002/ajh.21566. Am J Hematol. 2010. PMID: 20029948 Free article. No abstract available.

7

Noncalcified coronary plaque in systemic lupus erythematosus.

Kiani AN, Vogel-Claussen J, Magder LS, Petri M. Kiani AN, et al. Among authors: petri m. J Rheumatol. 2010 Mar;37(3):579-84. doi: 10.3899/jrheum.090824. Epub 2010 Jan 28. J Rheumatol. 2010. PMID: 20110529

8

Quality-of-life measurements versus disease activity in systemic lupus erythematosus.

Kiani AN, Petri M. Kiani AN, et al. Among authors: petri m. Curr Rheumatol Rep. 2010 Aug;12(4):250-8. doi: 10.1007/s11926-010-0114-1. Curr Rheumatol Rep. 2010. PMID: 20586000 Review.

9

Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years.

Kiani AN, Magder LS, Petri M. Kiani AN, et al. Among authors: petri m. Rheumatol Int. 2012 Sep;32(9):2701-5. doi: 10.1007/s00296-011-2048-y. Epub 2011 Jul 27. Rheumatol Int. 2012. PMID: 21792642 Free PMC article.

10

Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus.

Kiani AN, Post WS, Magder LS, Petri M. Kiani AN, et al. Among authors: petri m. Rheumatology (Oxford). 2011 Nov;50(11):2071-9. doi: 10.1093/rheumatology/ker285. Epub 2011 Aug 28. Rheumatology (Oxford). 2011. PMID: 21875880 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,053 results

Search Page

Filters